ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

NMRD Nemaura Medical Inc

0.1053
0.00 (0.00%)
2024年4月26日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Nemaura Medical Inc NMRD NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 0.1053 09:00:00
始値 安値 高値 終値 前日終値
0.1053 0.1053
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2005:05EDGAR2Form PRE 14C - Other preliminary information statements
2024/4/1105:16EDGAR2Form 8-K - Current report
2024/2/2706:05EDGAR2Form 8-K - Current report
2024/1/2306:15GLOBEMaxim Group LLC to Host the 2024 Healthcare IT Virtual..
2024/1/1807:17EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/1/1807:15EDGAR2Form DEF 14A - Other definitive proxy statements
2024/1/1007:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1007:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/0406:30EDGAR2Form 8-K - Current report
2024/1/0321:00EDGAR2Form 8-K - Current report
2024/1/0321:00GLOBEImportant Update on Listing Status and Strategic Direction
2023/12/1322:00EDGAR2Form 8-K - Current report
2023/12/1322:00GLOBENemaura Medical Inc. Receives Positive Nasdaq Listing..
2023/12/0800:46EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/11/2122:38EDGAR2Form 8-K - Current report
2023/11/2122:30GLOBENemaura Medical Inc. Secures $10 Million Non-Dilutive Credit..
2023/11/1422:00GLOBENemaura Launches Direct to Consumer Offering of Metabolic..
2023/11/1406:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1406:15EDGAR2Form 8-K - Current report
2023/11/1406:14GLOBENemaura Medical Reports Fiscal Second Quarter 2024 Results..
2023/10/1305:05EDGAR2Form 8-K - Current report
2023/10/0705:10EDGAR2Form 8-K - Current report
2023/9/2622:50GLOBENemaura Medical Announces Appointment of Mr Nikolai Rozanov..
2023/9/2304:05GLOBEMaxim Group LLC to Host the Virtual Tech Conference Series:..
2023/9/1822:15GLOBENemaura Medical to Present at the Maxim Group Emerging..
2023/9/1421:00EDGAR2Form 8-K - Current report
2023/9/1421:00GLOBENemaura Medical Provides Update on Nasdaq Compliance Status..
2023/9/1321:03EDGAR2Form 8-K - Current report
2023/9/1321:00GLOBENemaura Medical Announces Interim Results from its..
2023/9/1222:26GLOBENemaura Medical Announces Participation at HLTH 2023, Las..
2023/9/1205:41EDGAR2Form 424B8 - Prospectus filed pursuant to Rule 424(b)(8)
2023/9/1122:00EDGAR2Form 8-K - Current report
2023/9/0905:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/9/0905:15EDGAR2Form DEF 14A - Other definitive proxy statements
2023/8/1721:30EDGAR2Form 8-K - Current report
2023/8/1721:30GLOBENemaura Medical Announces SFDA Approval of sugarBEAT®
2023/8/1421:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1421:30EDGAR2Form 8-K - Current report
2023/8/1421:30GLOBENemaura Medical Reports Fiscal First Quarter 2024 Results..
2023/8/1206:07EDGAR2Form 8-K - Current report
2023/8/1205:05GLOBENemaura Medical Secures $6.5m in Non-Dilutive Funding
2023/8/1105:05EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/8/0405:08EDGAR2Form POS AM - Post-Effective amendments for registration..
2023/7/1722:30EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
2023/7/1422:25GLOBENemaura Medical Reports Financial Results and Provides..
2023/7/1422:18EDGAR2Form 8-K - Current report
2023/7/1405:31EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2023/6/2919:05EDGAR2Form NT 10-K - Notification of inability to timely file Form..
2023/6/2722:00GLOBENemaura Medical Scales-Up Pilot Expansion of proBEAT™; 56..
2023/6/2221:00GLOBENemaura Medical to Participate at the Collision Conference..

最近閲覧した銘柄

Delayed Upgrade Clock